Fridays vs Trinity Meds

Neither Fridays nor Trinity Meds has an FDA warning letter on record. On compounded tirzepatide injection, Trinity Meds costs $2,520 less a year at standing rates: $149 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Trinity Meds

Fridays logo

Fridays

5.8/10

Trinity Meds logo

Trinity Meds

9.3/10

FDA warning letters
None on record
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
Lowest standing price
$249/moCompounded semaglutide injection
$99/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Fridays nor Trinity Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Trinity Meds 9.3. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Trinity Meds has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Trinity Meds names four pharmacies.

  3. 03

    On compounded tirzepatide injection, Trinity Meds costs $2,520 less a year at standing rates: $149 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Trinity Meds lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Trinity Meds

Compounded semaglutide injection

$249/mo

$2,988 a year

$99/moLower

$1,188 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$149/moLower

$1,788 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None on the monthly plan; multi-month plans are prepaid and non-refundable
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
All payments are final and non-refundable, except a partial refund if you are medically disqualified

Read off each seller’s own pages. Fridays: October 30, 2026. Trinity Meds: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Trinity Meds does not price
  • Publishes no state list

The case for Trinity Meds

9.3/10
  • $1,800 a year less on compounded semaglutide injection
  • $2,520 a year less on compounded tirzepatide injection

Scores

Fridays 5.8 · Trinity Meds 9.3 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
9.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Trinity Meds: questions

Neither Fridays nor Trinity Meds has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Trinity Meds names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Trinity Meds, by $1,800 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Trinity Meds: $99 a month, about $1,188 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Trinity Meds states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified.
Neither Fridays nor Trinity Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Trinity Meds 9.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks